No abstract available
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Cell Cycle Proteins / genetics*
-
Cell Cycle Proteins / metabolism
-
F-Box Proteins / genetics*
-
F-Box Proteins / metabolism
-
F-Box-WD Repeat-Containing Protein 7
-
Gene Expression Regulation, Leukemic*
-
Humans
-
Hydrazones / pharmacology
-
PTEN Phosphohydrolase / genetics*
-
PTEN Phosphohydrolase / metabolism
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / metabolism
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Protein Biosynthesis / drug effects
-
Receptor, Notch1 / genetics*
-
Receptor, Notch1 / metabolism
-
Ribosomal Proteins / genetics*
-
Ribosomal Proteins / metabolism
-
Ribosomes / drug effects
-
Ribosomes / genetics
-
Ribosomes / metabolism
-
Signal Transduction
-
Thiazoles / pharmacology
-
Triterpenes / pharmacology
-
Ubiquitin-Protein Ligases / genetics*
-
Ubiquitin-Protein Ligases / metabolism
Substances
-
4EGI-1 compound
-
Antineoplastic Agents
-
Cell Cycle Proteins
-
F-Box Proteins
-
F-Box-WD Repeat-Containing Protein 7
-
FBXW7 protein, human
-
Hydrazones
-
NOTCH1 protein, human
-
Receptor, Notch1
-
Ribosomal Proteins
-
Thiazoles
-
Triterpenes
-
silvestrol
-
Ubiquitin-Protein Ligases
-
PTEN Phosphohydrolase
-
PTEN protein, human